Expanding Echo Capacity
UltraSight™ is an AI-powered cardiac workflow company advancing access to high-quality cardiac ultrasound.
The UltraSight EchoSystem™ brings together structured training, real-time AI guidance & interpratation, and advanced analytics – so clinical providers can perform focused echocardiography at the bedside, under qualified physician oversight.
Ultrasight’s
360° EchoSystem
One connected solution: training,
AI-guided acquisition, interpretation, workflow integration, and ongoing echo lab stewardship.
The EchoSystem enables more healthcare professionals to perform AI-guided focused echocardiograms that answer specific clinical questions at the point of care – extending echo capacity across care settings.
Built to fit the workflows hospitals already run, it delivers cardiac insight when time is of the essence.
More Echo Capacity.
Less Backlog. Better Care.
By extending appropriate echo acquisition and interpretation beyond the cardiac sonographer, UltraSight™ helps hospitals direct specialized resources where they matter most – without disrupting clinical workflow.
The result: shorter inpatient and ICU echo backlogs, smoother patient flow,
greater outpatient capacity, and timely cardiac insight that creates measurable clinical, operational, and economic value.
Across the ICU, ER and Inpatient Settings
Faster cardiac
insight
Support timely assessment
directly at the bedside.
Fewer workflow bottlenecks
Trained ICU staff perform FoCUS within their existing workflow, supporting faster clinical decisions and appropriate disposition.
Less pressure on the echo lab
Reserve cardiac sonographer capacity for comprehensive and higher-complexity studies.
Clinically Validated
UltraSight’s pivotal study demonstrated that, after minimal training with AI real-time guidance, novice users could acquire diagnostic-quality cardiac ultrasound images in the majority of patients. Twelve studies presented across ACC, ASE, and ESC 2026 — including a JAMA Cardiology publication — show that people with no prior imaging experience, guided by UltraSight’s AI, can acquire diagnostic-quality cardiac ultrasound in under five minutes and screen accurately for aortic stenosis, hypertrophic cardiomyopathy, low ejection fraction, and LV enlargement. In the first head-to-head trial of two FDA-cleared AI guidance systems, UltraSight outperformed the comparator on image quality, feasibility, and accuracy for detecting EF
Published in American Heart Association’s journal Circulation: Cardiovascular Imaging
Who We Are
Who We Are
UltraSight is redefining how cardiac ultrasound is delivered – making diagnostic-quality imaging more accessible and more scalable across care settings and providers.
Our AI-powered EchoSystem pairs advanced technology with deep clinical and healthcare expertise, helping hospitals expand access to timely cardiac insight using the personnel and ultrasound carts they already have.
Our team is united by one mission: better cardiac care for more patients, wherever it’s needed.
Company Updates
Stay up to date with UltraSight’s latest announcements and updates.
